688068 热景生物
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)1.61530.580121.89716.1507.925
总资产报酬率 ROA (%)1.44925.04696.13313.7666.825
投入资产回报率 ROIC (%)1.57728.652111.84913.9717.697

边际利润分析
销售毛利率 (%)64.09853.71159.53863.01273.124
营业利润率 (%)11.24930.67248.13424.91617.761
息税前利润/营业总收入 (%)3.47329.29048.15124.51418.495
净利润/营业总收入 (%)11.53426.01241.01921.67316.039

收益指标分析
经营活动净收益/利润总额(%)11.865117.095102.71690.40268.453
价值变动净收益/利润总额(%)-61.0721.0150.9646.3786.938
营业外收支净额/利润总额(%)-1.387-1.454-0.101-0.4131.288

偿债能力分析
流动比率 (X)5.5063.5173.4294.07912.065
速动比率 (X)4.7053.2153.0773.20210.611
资产负债率 (%)5.56713.99221.15417.25410.525
带息债务/全部投入资本 (%)0.5862.1538.587--2.261
股东权益/带息债务 (%)16,802.4284,497.7711,050.88923,935.8604,260.006
股东权益/负债合计 (%)1,695.079611.307368.803476.954844.728
利息保障倍数 (X)-0.456-31.106738.811-81.99136.861

营运能力分析
应收账款周转天数 (天)66.1126.7272.1390.00054.972
存货周转天数 (天)267.74545.14231.8930.000307.021